• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒细胞毒性T淋巴细胞表位的MHC I类抗原加工与感染细胞中免疫蛋白酶体的水平相关。

MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.

作者信息

Sijts A J, Standera S, Toes R E, Ruppert T, Beekman N J, van Veelen P A, Ossendorp F A, Melief C J, Kloetzel P M

机构信息

Institute of Biochemistry, Charité, Humboldt University, Berlin, Germany.

出版信息

J Immunol. 2000 May 1;164(9):4500-6. doi: 10.4049/jimmunol.164.9.4500.

DOI:10.4049/jimmunol.164.9.4500
PMID:10779750
Abstract

Proteasomes are the major source for the generation of peptides bound by MHC class I molecules. To study the functional relevance of the IFN-gamma-inducible proteasome subunits low molecular mass protein 2 (LMP2), LMP7, and mouse embryonal cell (MEC) ligand 1 in Ag processing and concomitantly that of immunoproteasomes, we established the tetracycline-regulated mouse cell line MEC217, allowing the titrable formation of immunoproteasomes. Infection of MEC217 cells with Adenovirus type 5 (Ad5) and analysis of Ag presentation with Ad5-specific CTL showed that cells containing immunoproteasomes processed the viral early 1B protein (E1B)-derived epitope E1B192-200 with increased efficiency, thus allowing a faster detection of viral entry in induced cells. Importantly, optimal CTL activation was already achieved at submaximal immunosubunit expression. In contrast, digestion of E1B-polypeptide with purified proteasomes in vitro yielded E1B192-200 at quantities that were proportional to the relative contents of immunosubunits. Our data provide evidence that the IFN-gamma-inducible proteasome subunits, when present at relatively low levels as at initial stages of infection, already increase the efficiency of antigenic peptide generation and thereby enhance MHC class I Ag processing in infected cells.

摘要

蛋白酶体是与MHC I类分子结合的肽产生的主要来源。为了研究干扰素-γ诱导的蛋白酶体亚基低分子量蛋白2(LMP2)、LMP7和小鼠胚胎细胞(MEC)配体1在抗原加工中的功能相关性,以及免疫蛋白酶体的功能相关性,我们建立了四环素调控的小鼠细胞系MEC217,可滴定形成免疫蛋白酶体。用5型腺病毒(Ad5)感染MEC217细胞并用Ad5特异性CTL分析抗原呈递,结果表明含有免疫蛋白酶体的细胞能更高效地加工病毒早期1B蛋白(E1B)衍生的表位E1B192-200,从而能更快地检测到诱导细胞中的病毒进入。重要的是,在亚最大免疫亚基表达时就已实现最佳CTL激活。相比之下,在体外用纯化的蛋白酶体消化E1B多肽产生的E1B192-200的量与免疫亚基的相对含量成正比。我们的数据证明,干扰素-γ诱导的蛋白酶体亚基在感染初期以相对较低水平存在时,就已提高了抗原肽产生的效率,从而增强了感染细胞中MHC I类抗原的加工。

相似文献

1
MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.腺病毒细胞毒性T淋巴细胞表位的MHC I类抗原加工与感染细胞中免疫蛋白酶体的水平相关。
J Immunol. 2000 May 1;164(9):4500-6. doi: 10.4049/jimmunol.164.9.4500.
2
Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.蛋白酶体亚基LMP2、LMP7和MECL-1的过表达增强了免疫显性淋巴细胞性脉络丛脑膜炎病毒T细胞表位的呈递,但PA28α/β的过表达则无此作用。
J Immunol. 2000 Jul 15;165(2):768-78. doi: 10.4049/jimmunol.165.2.768.
3
Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.免疫蛋白酶体下调淋巴细胞性脉络丛脑膜炎病毒中一个隐性T细胞表位的呈递。
J Immunol. 2004 Sep 15;173(6):3925-34. doi: 10.4049/jimmunol.173.6.3925.
4
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.蛋白酶体免疫亚基或PA28的可控表达对细胞毒性T淋巴细胞表位呈递的差异影响
J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483.
5
IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.干扰素-γ暴露了HIV-1逆转录酶中一个隐藏的细胞毒性T淋巴细胞表位。
J Immunol. 1999 Jun 15;162(12):7075-9.
6
Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.高效生成乙型肝炎病毒细胞毒性T淋巴细胞表位需要免疫蛋白酶体的结构特征。
J Exp Med. 2000 Feb 7;191(3):503-14. doi: 10.1084/jem.191.3.503.
7
Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.金属肽酶和蛋白酶体的顺序切割参与了HIV-1包膜蛋白表位的加工,以进行内源性MHC I类抗原呈递。
J Immunol. 2000 May 15;164(10):5070-7. doi: 10.4049/jimmunol.164.10.5070.
8
Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.蛋白酶体既能产生也能破坏MHC I类表位:胞质溶胶中存在非蛋白酶体表位产生的证据。
J Immunol. 1998 Jul 1;161(1):112-21.
9
Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.蛋白酶体活性限制了γ干扰素刺激后MHC I类分子的组装。
J Immunol. 1997 Dec 15;159(12):5896-904.
10
Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.蛋白酶体和半胱氨酸蛋白酶在MHC I类抗原呈递中的选择性参与。
J Immunol. 1997 Dec 15;159(12):5769-72.

引用本文的文献

1
Current landscape of the immunoproteasome: implications for disease and therapy.免疫蛋白酶体的当前态势:对疾病与治疗的影响
Cell Death Discov. 2025 Aug 25;11(1):406. doi: 10.1038/s41420-025-02698-0.
2
Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma.对蛋白酶体亚基β型8(PSMB8)的多方面研究为甲状腺癌的预后预测和免疫靶点提供了见解。
PLoS One. 2025 May 7;20(5):e0323013. doi: 10.1371/journal.pone.0323013. eCollection 2025.
3
Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells.
吉西他滨调节 HLA-I 调控以改善胰腺癌细胞的肿瘤抗原呈递。
Int J Mol Sci. 2024 Mar 11;25(6):3211. doi: 10.3390/ijms25063211.
4
The role of cellular proteostasis in antitumor immunity.细胞蛋白稳态在抗肿瘤免疫中的作用。
J Biol Chem. 2022 May;298(5):101930. doi: 10.1016/j.jbc.2022.101930. Epub 2022 Apr 11.
5
The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer.免疫蛋白酶体亚基在癌症中的功能和机制作用。
Cells. 2021 Dec 20;10(12):3587. doi: 10.3390/cells10123587.
6
The Function of Immunoproteasomes-An Immunologists' Perspective.免疫蛋白酶体的功能——免疫学家的视角。
Cells. 2021 Nov 30;10(12):3360. doi: 10.3390/cells10123360.
7
Mechanistic diversity in MHC class I antigen recognition.MHC I 类抗原识别中的机制多样性。
Biochem J. 2021 Dec 22;478(24):4187-4202. doi: 10.1042/BCJ20200910.
8
The Ubiquitin-Proteasome System in Immune Cells.免疫细胞中的泛素-蛋白酶体系统。
Biomolecules. 2021 Jan 5;11(1):60. doi: 10.3390/biom11010060.
9
Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.基于 mRNA 的蛋白质补充治疗靶向肺部疾病的最新进展。
Mol Ther. 2019 Apr 10;27(4):803-823. doi: 10.1016/j.ymthe.2019.02.019. Epub 2019 Mar 6.
10
Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.蛋白酶体激活作为靶向蛋白毒性疾病的新治疗方法。
J Med Chem. 2019 Jul 25;62(14):6469-6481. doi: 10.1021/acs.jmedchem.9b00101. Epub 2019 Mar 14.